BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15081879)

  • 1. Protection against cisplatin ototoxicity by adenosine agonists.
    Whitworth CA; Ramkumar V; Jones B; Tsukasaki N; Rybak LP
    Biochem Pharmacol; 2004 May; 67(9):1801-7. PubMed ID: 15081879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and function of adenosine receptors in the chinchilla cochlea.
    Ford MS; Maggirwar SB; Rybak LP; Whitworth C; Ramkumar V
    Hear Res; 1997 Mar; 105(1-2):130-40. PubMed ID: 9083810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of protective agents against cisplatin ototoxicity.
    Rybak LP; Husain K; Morris C; Whitworth C; Somani S
    Am J Otol; 2000 Jul; 21(4):513-20. PubMed ID: 10912697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of adenosine receptors in the cochlea by cisplatin.
    Ford MS; Nie Z; Whitworth C; Rybak LP; Ramkumar V
    Hear Res; 1997 Sep; 111(1-2):143-52. PubMed ID: 9307320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine A1 Receptor Protects Against Cisplatin Ototoxicity by Suppressing the NOX3/STAT1 Inflammatory Pathway in the Cochlea.
    Kaur T; Borse V; Sheth S; Sheehan K; Ghosh S; Tupal S; Jajoo S; Mukherjea D; Rybak LP; Ramkumar V
    J Neurosci; 2016 Apr; 36(14):3962-77. PubMed ID: 27053204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ginkgo biloba extract (EGb 761) protects against cisplatin-induced ototoxicity in rats.
    Huang X; Whitworth CA; Rybak LP
    Otol Neurotol; 2007 Sep; 28(6):828-33. PubMed ID: 17450108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of antioxidants and other agents to prevent cisplatin ototoxicity.
    Rybak LP; Whitworth C; Somani S
    Laryngoscope; 1999 Nov; 109(11):1740-4. PubMed ID: 10569399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective role of resveratrol against cisplatin induced ototoxicity in guinea pigs.
    Yumusakhuylu AC; Yazici M; Sari M; Binnetoglu A; Kosemihal E; Akdas F; Sirvanci S; Yuksel M; Uneri C; Tutkun A
    Int J Pediatr Otorhinolaryngol; 2012 Mar; 76(3):404-8. PubMed ID: 22261612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive limb remote ischemic preconditioning contributes neuroprotective effects via activation of adenosine A1 receptor and redox status after transient focal cerebral ischemia in rats.
    Hu S; Dong H; Zhang H; Wang S; Hou L; Chen S; Zhang J; Xiong L
    Brain Res; 2012 Jun; 1459():81-90. PubMed ID: 22560096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ototoxicity. Amelioration by protective agents.
    Rybak LP; Somani S
    Ann N Y Acad Sci; 1999 Nov; 884():143-51. PubMed ID: 10842591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose dependent protection by lipoic acid against cisplatin-induced ototoxicity in rats: antioxidant defense system.
    Rybak LP; Husain K; Whitworth C; Somani SM
    Toxicol Sci; 1999 Feb; 47(2):195-202. PubMed ID: 10220857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental studies of the protective effect of deferoxamine mesilate on cisplatin induced toxicity].
    Watanabe H; Kanno H
    Nihon Jibiinkoka Gakkai Kaiho; 1998 Aug; 101(8):967-78. PubMed ID: 9778942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post exposure administration of A(1) adenosine receptor agonists attenuates noise-induced hearing loss.
    Wong AC; Guo CX; Gupta R; Housley GD; Thorne PR; Vlajkovic SM
    Hear Res; 2010 Feb; 260(1-2):81-8. PubMed ID: 19995597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of A1 and A2A adenosine receptor agonists on kainic acid excitotoxicity in the guinea pig cochlea.
    Tabuchi K; Sakai S; Nakayama M; Nishimura B; Hayashi K; Hirose Y; Hara A
    Neurosci Lett; 2012 Jun; 518(1):60-3. PubMed ID: 22580201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the adenosinergic system in lung fibrosis.
    Della Latta V; Cabiati M; Rocchiccioli S; Del Ry S; Morales MA
    Pharmacol Res; 2013 Oct; 76():182-9. PubMed ID: 23994158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of pH on the ototoxicity of cisplatin: a round window application study.
    Tanaka F; Whitworth CA; Rybak LP
    Hear Res; 2003 Mar; 177(1-2):21-31. PubMed ID: 12618314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Round window application of D-methionine provides complete cisplatin otoprotection.
    Korver KD; Rybak LP; Whitworth C; Campbell KM
    Otolaryngol Head Neck Surg; 2002 Jun; 126(6):683-9. PubMed ID: 12087338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transtympanic administration of short interfering (si)RNA for the NOX3 isoform of NADPH oxidase protects against cisplatin-induced hearing loss in the rat.
    Mukherjea D; Jajoo S; Kaur T; Sheehan KE; Ramkumar V; Rybak LP
    Antioxid Redox Signal; 2010 Sep; 13(5):589-98. PubMed ID: 20214492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Research progress on mechanism of cisplatin ototoxicity and protective agents against the ototoxic effects].
    Liao YJ; Tang H
    Sheng Li Ke Xue Jin Zhan; 2003 Jul; 34(3):266-9. PubMed ID: 14628479
    [No Abstract]   [Full Text] [Related]  

  • 20. Candidate's thesis: enhancing intrinsic cochlear stress defenses to reduce noise-induced hearing loss.
    Kopke RD; Coleman JK; Liu J; Campbell KC; Riffenburgh RH
    Laryngoscope; 2002 Sep; 112(9):1515-32. PubMed ID: 12352659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.